US Stock MarketDetailed Quotes

JSPR Jasper Therapeutics

Watchlist
  • 22.030
  • +0.760+3.57%
Close Nov 4 16:00 ET
  • 20.930
  • -1.100-4.99%
Post 20:02 ET
332.77MMarket Cap-4319P/E (TTM)

Jasper Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-10.29%15.99M
8.07%15.07M
34.50%68.86M
28.94%17.73M
52.36%19.36M
49.02%17.83M
9.15%13.95M
38.99%51.2M
13.78%13.75M
26.08%12.71M
Selling and administrative expenses
3.69%4.7M
15.26%4.77M
3.06%17.08M
-12.88%3.89M
22.46%4.51M
18.34%4.53M
-9.76%4.14M
45.19%16.57M
30.36%4.47M
27.50%3.69M
-General and administrative expense
3.69%4.7M
15.26%4.77M
3.06%17.08M
-12.88%3.89M
22.46%4.51M
18.34%4.53M
-9.76%4.14M
45.19%16.57M
30.36%4.47M
27.50%3.69M
Research and development costs
-15.05%11.3M
5.03%10.3M
49.55%51.79M
49.05%13.84M
64.58%14.85M
63.45%13.3M
19.75%9.81M
36.21%34.63M
7.22%9.28M
25.51%9.02M
Operating profit
10.29%-15.99M
-8.07%-15.07M
-34.50%-68.86M
-28.94%-17.73M
-52.36%-19.36M
-49.02%-17.83M
-9.15%-13.95M
-38.99%-51.2M
-13.78%-13.75M
-26.08%-12.71M
Net non-operating interest income expense
0.97%1.45M
26.46%1.39M
641.65%5.2M
254.60%1.23M
453.28%1.43M
1,460.87%1.44M
54,700.00%1.1M
701K
348K
2,977.78%259K
Non-operating interest income
0.97%1.45M
26.46%1.39M
641.65%5.2M
254.60%1.23M
453.28%1.43M
1,460.87%1.44M
54,700.00%1.1M
--701K
--348K
--259K
Other net income (expense)
-112.86%-40K
97.02%-42K
-106.27%-803K
-147.87%-90K
-34.30%385K
-78.80%311K
-113.33%-1.41M
106.75%12.81M
-93.78%188K
-91.22%586K
Gain on sale of security
----
----
-107.99%-575K
--0
----
----
-109.50%-575K
339.92%7.2M
200.00%150K
-65.56%155K
Special income (charges)
--0
97.38%-20K
-99.69%18K
-67.06%28K
-20.85%334K
-32.80%420K
-116.63%-764K
-38.29%5.73M
-97.21%85K
-93.22%422K
-Less：Restructuring and merger&acquisition
--0
-97.38%20K
99.69%-18K
67.06%-28K
20.85%-334K
32.80%-420K
116.63%764K
38.29%-5.73M
97.21%-85K
93.22%-422K
Other non- operating income (expenses)
63.30%-40K
68.57%-22K
-113.91%-246K
-151.06%-118K
466.67%51K
-3,533.33%-109K
5.41%-70K
-43.75%-115K
---47K
--9K
Income before tax
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
-247.68%-11.86M
Income tax
Net income
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
-247.68%-11.86M
Net income continuous Operations
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
-247.68%-11.86M
Minority interest income
Net income attributable to the parent company
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
-247.68%-11.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
-247.68%-11.86M
Basic earnings per share
34.01%-0.97
36.42%-1.03
40.17%-6.18
58.33%-1.5
50.00%-1.6
49.31%-1.47
-170.00%-1.62
61.60%-10.33
-50.47%-3.6
53.62%-3.2
Diluted earnings per share
34.01%-0.97
36.42%-1.03
40.17%-6.18
58.33%-1.5
50.00%-1.6
49.31%-1.47
-170.00%-1.62
61.60%-10.33
-50.47%-3.6
53.62%-3.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -10.29%15.99M8.07%15.07M34.50%68.86M28.94%17.73M52.36%19.36M49.02%17.83M9.15%13.95M38.99%51.2M13.78%13.75M26.08%12.71M
Selling and administrative expenses 3.69%4.7M15.26%4.77M3.06%17.08M-12.88%3.89M22.46%4.51M18.34%4.53M-9.76%4.14M45.19%16.57M30.36%4.47M27.50%3.69M
-General and administrative expense 3.69%4.7M15.26%4.77M3.06%17.08M-12.88%3.89M22.46%4.51M18.34%4.53M-9.76%4.14M45.19%16.57M30.36%4.47M27.50%3.69M
Research and development costs -15.05%11.3M5.03%10.3M49.55%51.79M49.05%13.84M64.58%14.85M63.45%13.3M19.75%9.81M36.21%34.63M7.22%9.28M25.51%9.02M
Operating profit 10.29%-15.99M-8.07%-15.07M-34.50%-68.86M-28.94%-17.73M-52.36%-19.36M-49.02%-17.83M-9.15%-13.95M-38.99%-51.2M-13.78%-13.75M-26.08%-12.71M
Net non-operating interest income expense 0.97%1.45M26.46%1.39M641.65%5.2M254.60%1.23M453.28%1.43M1,460.87%1.44M54,700.00%1.1M701K348K2,977.78%259K
Non-operating interest income 0.97%1.45M26.46%1.39M641.65%5.2M254.60%1.23M453.28%1.43M1,460.87%1.44M54,700.00%1.1M--701K--348K--259K
Other net income (expense) -112.86%-40K97.02%-42K-106.27%-803K-147.87%-90K-34.30%385K-78.80%311K-113.33%-1.41M106.75%12.81M-93.78%188K-91.22%586K
Gain on sale of security ---------107.99%-575K--0---------109.50%-575K339.92%7.2M200.00%150K-65.56%155K
Special income (charges) --097.38%-20K-99.69%18K-67.06%28K-20.85%334K-32.80%420K-116.63%-764K-38.29%5.73M-97.21%85K-93.22%422K
-Less：Restructuring and merger&acquisition --0-97.38%20K99.69%-18K67.06%-28K20.85%-334K32.80%-420K116.63%764K38.29%-5.73M97.21%-85K93.22%-422K
Other non- operating income (expenses) 63.30%-40K68.57%-22K-113.91%-246K-151.06%-118K466.67%51K-3,533.33%-109K5.41%-70K-43.75%-115K---47K--9K
Income before tax 9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M-247.68%-11.86M
Income tax
Net income 9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M-247.68%-11.86M
Net income continuous Operations 9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M-247.68%-11.86M
Minority interest income
Net income attributable to the parent company 9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M-247.68%-11.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M-247.68%-11.86M
Basic earnings per share 34.01%-0.9736.42%-1.0340.17%-6.1858.33%-1.550.00%-1.649.31%-1.47-170.00%-1.6261.60%-10.33-50.47%-3.653.62%-3.2
Diluted earnings per share 34.01%-0.9736.42%-1.0340.17%-6.1858.33%-1.550.00%-1.649.31%-1.47-170.00%-1.6261.60%-10.33-50.47%-3.653.62%-3.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data